Nadia Aspromonte to Thromboembolism
This is a "connection" page, showing publications Nadia Aspromonte has written about Thromboembolism.
Connection Strength
0.081
-
Clinical relevance of pharmacokinetic and pharmacodynamic properties of edoxaban when treating patients with atrial fibrillation and heart failure. Expert Opin Drug Metab Toxicol. 2017 Jan; 13(1):113-122.
Score: 0.065
-
Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials. Monaldi Arch Chest Dis. 2017 05 18; 87(1):805.
Score: 0.017